User profiles for Eric D. Whitman
 | Eric WhitmanAtlantic Health System Cancer Care Verified email at atlantichealth.org Cited by 5867 |
[HTML][HTML] gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma
…, B Curti, PD Leming, ED Whitman… - … England Journal of …, 2011 - Mass Medical Soc
Background Stimulating an immune response against cancer with the use of vaccines remains
a challenge. We hypothesized that combining a melanoma vaccine with interleukin-2, an …
a challenge. We hypothesized that combining a melanoma vaccine with interleukin-2, an …
Lifileucel, a tumor-infiltrating lymphocyte therapy, in metastatic melanoma
…, AC Pavlick, ED Whitman… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE Effective treatment options are limited for patients with advanced (metastatic or
unresectable) melanoma who progress after immune checkpoint inhibitors and targeted …
unresectable) melanoma who progress after immune checkpoint inhibitors and targeted …
[PDF][PDF] Unbiased screens show CD8+ T cells of COVID-19 patients recognize shared epitopes in SARS-CoV-2 that largely reside outside the spike protein
…, KJ Olivier, LR Buckner, AT Alistar, ED Whitman… - Immunity, 2020 - cell.com
Developing effective strategies to prevent or treat coronavirus disease 2019 (COVID-19)
requires understanding the natural immune response to severe acute respiratory syndrome …
requires understanding the natural immune response to severe acute respiratory syndrome …
Comparative analysis of laparoscopic versus open splenectomy
…, JC Langer, MA Quasebarth, ED Whitman - The American journal of …, 1996 - Elsevier
BACKGROUND: Laparoscopic splenectomy (LS) has been used to treat a variety of splenic
disorders. However, there have been few direct comparisons of this approach with open …
disorders. However, there have been few direct comparisons of this approach with open …
Clinical responses of oncolytic coxsackievirus A21 (V937) in patients with unresectable melanoma
…, GA Daniels, S Hallmeyer, ED Whitman… - Journal of Clinical …, 2021 - ingentaconnect.com
PURPOSE We evaluated the activity of intratumoral Coxsackievirus A21 (V937) in 57
patients with unresectable stage IIIC or IV melanoma. PATIENTS AND METHODS In this …
patients with unresectable stage IIIC or IV melanoma. PATIENTS AND METHODS In this …
Efficacy and safety of CD24Fc in hospitalised patients with COVID-19: a randomised, double-blind, placebo-controlled, phase 3 study
…, Z Li, JB Cohen, ED Whitman, D Byrne… - The Lancet Infectious …, 2022 - thelancet.com
Background Non-antiviral therapeutic options are required for the treatment of hospitalised
patients with COVID-19. CD24Fc is an immunomodulator with potential to reduce the …
patients with COVID-19. CD24Fc is an immunomodulator with potential to reduce the …
[HTML][HTML] An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0
…, WJ Urba, RL White, ED Whitman… - … for immunotherapy of …, 2018 - Springer
Background Cancer immunotherapy has been firmly established as a standard of care for
patients with advanced and metastatic melanoma. Therapeutic outcomes in clinical trials have …
patients with advanced and metastatic melanoma. Therapeutic outcomes in clinical trials have …
Integrating 31-gene expression profiling with clinicopathologic features to optimize cutaneous melanoma sentinel lymph node metastasis prediction
ED Whitman, VP Koshenkov, BR Gastman… - JCO Precision …, 2021 - ascopubs.org
PURPOSE National guidelines recommend sentinel lymph node biopsy (SLNB) be offered
to patients with > 10% likelihood of sentinel lymph node (SLN) positivity. On the other hand, …
to patients with > 10% likelihood of sentinel lymph node (SLN) positivity. On the other hand, …
[PDF][PDF] Long-term follow up of lifileucel (LN-144) cryopreserved autologous tumor infiltrating lymphocyte therapy in patients with advanced melanoma progressed on …
…, E Domingo Musibay, AC Pavlick, ED Whitman… - J Clin Oncol, 2020 - iovance.com
… (1) Larkin J, Minor D, D'Angelo S, et al. Overall Survival in Patients With Advanced
Melanoma Who Received Nivolumab Versus Investigator's Choice Chemotherapy in …
Melanoma Who Received Nivolumab Versus Investigator's Choice Chemotherapy in …
Final data from CALM: A phase II study of Coxsackievirus A21 (CVA21) oncolytic virus immunotherapy in patients with advanced melanoma.
…, S Hallmeyer, J Lutzky, SM Schultz, ED Whitman… - 2015 - ascopubs.org
9030 Background: CVA21 (CAVATAK) is a novel bio-selected oncolytic and immunotherapeutic
strain of Coxsackievirus A21. Intratumoral (it) CVA21 injection initiates preferential tumor …
strain of Coxsackievirus A21. Intratumoral (it) CVA21 injection initiates preferential tumor …